Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Favaudon

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Bulletin Du Cancer|January 7, 2006
[Biological basis for concomitant chemoradiotherapy in carcinomas]Vincent Favaudon, Georges Noël
Bulletin Du Cancer|April 7, 2011
[DNA repair and tumour radiosensitivity: focus on ATM gene]Christophe Hennequin, Laurent Quero, Vincent Favaudon
Bulletin Du Cancer|January 7, 2006
[Targeted therapies and radiotherapy]Christophe Hennequin, Nicole Giocanti, Vincent Favaudon
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 12, 2008
[Determinants and predictive factors of tumour radiosensitivity]Christophe Hennequin, Laurent Quero, Vincent Favaudon
Medical Physics|August 18, 2021
Model studies of the role of oxygen in the FLASH effectVincent Favaudon, Rudi Labarbe, Charles L Limoli
BMC Pharmacology|April 4, 2002
The farnesyl transferase inhibitor RPR-130401 does not alter radiation susceptibility in human tumor cells with a K-Ras mutation in spite of large changes in ploidy and lamin B distributionFrédérique Mégnin-Chanet, François Lavelle, Vincent Favaudon
Bulletin Du Cancer|March 1, 2003
[Chemoradiotherapy of solid tumours in the adult: current views and perspectives]Georges Noël, Jean-Jacques Mazeron, Vincent Favaudon
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 2020
A physicochemical model of reaction kinetics supports peroxyl radical recombination as the main determinant of the FLASH effectRudi Labarbe, Lucian Hotoiu, Julie Barbier, et al.
The Prostate|November 11, 2009
Antagonistic interaction between bicalutamide (Casodex) and radiation in androgen-positive prostate cancer LNCaP cellsLaurent Quéro, Nicole Giocanti, Christophe Hennequin, et al.
DNA Repair|November 21, 2009
Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivityMarie Fernet, Frédérique Mégnin-Chanet, Janet Hall, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Bulletin Du Cancer|January 7, 2006
[Biological basis for concomitant chemoradiotherapy in carcinomas]Vincent Favaudon, Georges Noël
Bulletin Du Cancer|April 7, 2011
[DNA repair and tumour radiosensitivity: focus on ATM gene]Christophe Hennequin, Laurent Quero, Vincent Favaudon
Bulletin Du Cancer|January 7, 2006
[Targeted therapies and radiotherapy]Christophe Hennequin, Nicole Giocanti, Vincent Favaudon
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 12, 2008
[Determinants and predictive factors of tumour radiosensitivity]Christophe Hennequin, Laurent Quero, Vincent Favaudon
Medical Physics|August 18, 2021
Model studies of the role of oxygen in the FLASH effectVincent Favaudon, Rudi Labarbe, Charles L Limoli
BMC Pharmacology|April 4, 2002
The farnesyl transferase inhibitor RPR-130401 does not alter radiation susceptibility in human tumor cells with a K-Ras mutation in spite of large changes in ploidy and lamin B distributionFrédérique Mégnin-Chanet, François Lavelle, Vincent Favaudon
Bulletin Du Cancer|March 1, 2003
[Chemoradiotherapy of solid tumours in the adult: current views and perspectives]Georges Noël, Jean-Jacques Mazeron, Vincent Favaudon
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 15, 2020
A physicochemical model of reaction kinetics supports peroxyl radical recombination as the main determinant of the FLASH effectRudi Labarbe, Lucian Hotoiu, Julie Barbier, et al.
The Prostate|November 11, 2009
Antagonistic interaction between bicalutamide (Casodex) and radiation in androgen-positive prostate cancer LNCaP cellsLaurent Quéro, Nicole Giocanti, Christophe Hennequin, et al.
DNA Repair|November 21, 2009
Control of the G2/M checkpoints after exposure to low doses of ionising radiation: implications for hyper-radiosensitivityMarie Fernet, Frédérique Mégnin-Chanet, Janet Hall, et al.
Pageof 6